ADC Therapeutics SA, a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent antibody drug conjugates (ADCs) for patients suffering from hematological malignancies and solid...
view press release
May 01, 2020, 09:15 AM
|
Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced that it has entered into an exchange agreement with three holders of the Company’s 3.25% Senior Convertible Notes due 2020 (the “Existing Notes”)...
view press release
February 25, 2020, 09:00 AM
|
SHINE Medical Technologies, Inc. announced that it executed a term sheet providing for up to $125 million of debt and equity financing with Deerfield Management Company, L.P. (Deerfield), a New York headquartered healthcare investment firm. SHINE...
view press release
October 10, 2014, 07:09 AM
|
Cytomedix, Inc, a leading developer of biologically active regenerative therapies, announced receipt, following satisfaction of closing conditions, of the second tranche of the gross proceeds in the amount of $26 million (for a total $35 million) in...
view press release
June 27, 2014, 07:13 AM
|
Deerfield Management Company announced it has committed to invest up to $60 million in KemPharm, Inc. through a $10 million senior secured convertible note and a $50 million senior secured term debt facility. The facility provides KemPharm with...
view press release
June 04, 2014, 07:12 AM
|
OMNIlife science, Inc. (also known as "OMNI"), an established medical technology company targeting the $15 billion and rapidly growing global hip and knee replacement medical device sector, announces the closing of a $27.5 million debt financing....
view press release
April 10, 2014, 07:46 AM
|